Evidence map›Paper›PMID 29572711›Full record

ArticleEndocrine2018

Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major.

Alberto G Ambrogio, Leila Danesi, Marina Baldini, Raffaella Radin, Elena Cassinerio, Giovanna Graziadei, Nadia Mirra, Emanuela D'Angelo, Alessia Marcon, Marta Mancarella and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Alberto G AmbrogioNeuroendocrine Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Leila DanesiDivision of Endocrine and Metabolic Diseases, Ospedale San Luca, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Marina BaldiniDepartment of Medicine and Medical Specialties, Rare Diseases Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Raffaella RadinDivision of Endocrine and Metabolic Diseases, Ospedale San Luca, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Elena CassinerioDepartment of Medicine and Medical Specialties, Rare Diseases Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giovanna GraziadeiDepartment of Medicine and Medical Specialties, Rare Diseases Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Nadia MirraFondazione Policlinico Mangiagalli Regina Elena, Second Pediatric Clinic, University of Milan, Milan, Italy.
Emanuela D'AngeloFondazione Policlinico Mangiagalli Regina Elena, Second Pediatric Clinic, University of Milan, Milan, Italy.
Alessia MarconDepartment of Medicine and Medical Specialties, Rare Diseases Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Marta MancarellaDepartment of Medicine and Medical Specialties, Rare Diseases Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Alessandra OrsattiDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Federico BonettiPediatric Haematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Massimo ScacchiDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Maria Domenica CappelliniDepartment of Medicine and Medical Specialties, Rare Diseases Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Luca PersaniDivision of Endocrine and Metabolic Diseases, Ospedale San Luca, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Francesca Pecori GiraldiNeuroendocrine Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy. fpg@auxologico.it.ORCID 0000-0001-6065-7803
University of Milan · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIRCCS Istituto Auxologico Italiano · ITPoliclinico San Matteo Fondazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBeta-thalassemia major is a severe, congenital hematological disorder and, if untreated, leads to early mortality. Progress in therapeutical strategies improved clinical outcomes and life expectancy; however, increased survival led to the development of new disorders, including endocrinopathies. Little is known on the possible impairment of adrenocortical function, a potentially life-threatening condition, in long-term thalassaemic survivors. We therefore decided to assess adrenal reserve and the value of salivary cortisol during ACTH stimulation in the diagnosis of adrenocortical insufficiency in adult patients with β-thalassemia major.

methodsCross-sectional study including 72 adults with β-thalassemia major. Patients were tested with 1 µg ACTH for serum and salivary cortisol.

resultsSubnormal serum cortisol responses to ACTH stimulation (i.e., <500 nmol/l) were registered in 15 out of 72 patients. Salivary cortisol increased in parallel with serum cortisol and a clear-cut positive correlation was detected at each timepoint. Moreover, peak salivary cortisol values after ACTH stimulation were significantly lower in patients with impaired adrenal reserve (513.6 ± 52.33 vs. 914.1 ± 44.04 nmol/l p < 0.0001).

conclusionsOur results attest to the need for testing for adrenal insufficiency among adult thalassaemic patients, as up to 20% presented impaired adrenal reserve. Salivary and serum cortisol levels during stimulation with ACTH were closely correlated and the use of salivary cortisol sampling during ACTH testing may represent a surrogate to serum cortisol in these patients.

Indexed as

Adrenal InsufficiencyAdrenocorticotropic HormoneAdultbeta-ThalassemiaCross-Sectional StudiesFemaleHumansHydrocortisoneItalyMaleMiddle AgedPrevalenceSalivaYoung AdultAdrenocorticotropic HormoneHydrocortisoneAdrenocortical insufficiencyCortisol-binding globulinLow-dose ACTH stimulation testSalivary cortisolSerum cortisolβ-thalassemia major

Identifiers

PMID29572711
PMCPMC5893656
OpenAlexW2793167495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.